Back to Search
REBECCA ZON, MD
MD
Medical Oncology Physician
NPI: 1003344037IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
271931(MA)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
1014783(MA)
Education
UNIVERSITY OF MICHIGAN MEDICAL SCHOOL
Class of 2017
Research & Publications (9)
American Society of Clinical Oncology policy statement: the role of the oncologist in cancer prevention and risk assessment.
PMID 19075281·J Clin Oncol·2009
6-review
American Society of Clinical Oncology Statement on minimum standards and exemplary attributes of clinical trial sites.
PMID 18390967·J Clin Oncol·2008
6-review
A phase II study of pemetrexed as second-line chemotherapy for the treatment of metastatic castrate-resistant prostate cancer (CRPC); Hoosier Oncology Group GU03-67.
PMID 19605506·Ann Oncol·2009
3-trial
Use of 5-alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline.
PMID 19252137·J Clin Oncol·2009
6-review
A phase II study of oral enzastaurin in patients with metastatic breast cancer previously treated with an anthracycline and a taxane containing regimen.
PMID 19214387·Invest New Drugs·2009
3-trial
Use of 5alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline.
PMID 19249063·J Urol·2009
6-review
Hoosier Oncology Group randomized phase II study of docetaxel, vinorelbine, and estramustine in combination in hormone-refractory prostate cancer with pharmacogenetic survival analysis.
PMID 17062685·Clin Cancer Res·2006
3-trial
Combined anti-microtubule therapy: a phase II study of weekly docetaxel plus estramustine in patients with metastatic breast cancer.
PMID 12377650·Ann Oncol·2002
3-trial
Altretamine for the treatment of metastatic renal cell carcinoma. A Hoosier Oncology Group trial.
PMID 11561679·Invest New Drugs·2001
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 75 FRANCIS ST
BOSTON, MA 02115 - Phone
- (617) 732-5500
Quick Facts
- NPI
- 1003344037
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 9
- Publications
- 9
Are you this provider?
Claim Your Profile